QIAGEN and GENCURIX Announce QIAcuity Digital PCR IVD Assay Development Partnership
GENCURIX is the first development partner under QIAGEN's QIAcuityDx Partnering Program. This important advancement marks a significant step towards establishing a broad menu of in vitro diagnostic (IVD) assays on the QIAcuityDx Four platform, increasing access to digital PCR diagnostics.
The new partnership combines QIAGEN's QIAcuityDx digital PCR platform to advance sensitive, cost-effective oncology diagnostics with GENCURIX's expertise in multiplex assay development. The aim is to enable the creation of oncology IVD assays for both tissue and liquid biopsy applications, with flexible commercialization options and global reach through QIAGEN's Partnering Program.
'The QIAcuityDx Partnering Program is designed to enable the generation of a broad menu of IVD assays on the platform,' said Jonathan Arnold, Vice President and Head, Partnering for Precision Diagnostics at QIAGEN. 'The first partnership in this program with GENCURIX is an exciting moment, giving our oncology testing customers access to high-quality IVD assays that complement other established methods such as qPCR and NGS. We look forward to working with GENCURIX within this promising partner program.'
'This strategic partnership with QIAGEN represents a major inflection point for expanding our oncology molecular diagnostic technologies into the global market,' said Sang Rae Cho, CEO at GENCURIX. 'We are confident that the synergy between our diagnostic content and QIAGEN's platform will lead to global-standard precision cancer diagnostic solutions.'
The QIAcuityDx Partnering Program aims to support third-party assay development on QIAcuityDx, which is a member of the QIAcuity family of digital PCR systems that reached at the end of 2024 more than 2,700 cumulative placements since launch. These menu initiatives for clinical applications will leverage this installed base as well as build on the 2024 milestone of launching more than 130 new assays for QIAcuity for research applications, and complemented by the extensive menu of custom assays available on QIAGEN's GeneGlobe platform at geneglobe.qiagen.com.
GENCURIX will apply its proven expertise in complex, multiplex IVD assay development to create oncology tests The QIAcuityDx Four platform delivers a scalable and high-performance digital PCR solution for clinical laboratories. As global adoption of digital PCR grows, it is increasingly recognized as a complementary method to qPCR and NGS—particularly in oncology, infectious diseases, and rare genetic disorders. Through the QIAcuityDx Partnering Program, QIAGEN is opening its platform to third-party developers, encouraging innovation in order to offer laboratories a continuously expanding range of validated diagnostic tests.
GENCURIX will begin developing multiple oncology assays and pursue IVD regulatory approvals. GENCURIX, as the legal manufacturer of the assays, will be fully responsible for obtaining and maintaining all necessary regulatory approvals and certifications. Upon approval, the assays will be marketed through QIAGEN's global commercial infrastructure as part of the QIAcuityDx Partnering Program, ensuring streamlined access for laboratories worldwide.
By enabling third-party development, QIAGEN is addressing the growing demand for broader access to high-precision and cost-efficient diagnostic assays. The collaboration with GENCURIX represents the first step in building a robust and innovative assay ecosystem for the QIAcuityDx platform, backed by QIAGEN's distribution capabilities and technical support.
For more information about the QIAcuityDx Partnering Program please visit: www.qiagen.com/us/applications/digital-pcr-mdx/partnering.
About QIAGEN
QIAGEN N.V., a Netherlands-based holding company, is the leading global provider of Sample to Insight solutions, enabling customers to extract and gain valuable molecular insights from samples containing the building blocks of life. Our sample technologies isolate and process DNA, RNA and proteins from blood, tissue and other materials. Assay technologies prepare these biomolecules for analysis while bioinformatics software and knowledge bases can be used to interpret data to find actionable insights. Automation solutions bring these processes together into seamless and cost-effective workflows. QIAGEN serves over 500,000 customers globally in Life Sciences (academia, pharma R&D and industrial applications, primarily forensics) and Molecular Diagnostics for clinical healthcare. As of March 31, 2025, QIAGEN employed approximately 5,700 people in over 35 locations worldwide. For more information, visit www.qiagen.com.
About GENCURIX
GENCURIX Inc. is a molecular diagnostics company based in Seoul, South Korea, focused on developing dPCR-based diagnostics and liquid biopsy platforms. Its products include GenesWell™ BCT, a breast cancer prognostic test, and Droplex™, a diagnostic assay series for companion and stratification testing in multiple cancer types. For more information, visit www.gencurix.com.
Forward-Looking Statement
Certain statements in this press release may constitute forward-looking statements within the meaning of Section 27A of the U.S. Securities Act of 1933, as amended, and Section 21E of the U.S. Securities Exchange Act of 1934, as amended. These statements, including those regarding QIAGEN's products, development timelines, marketing and / or regulatory approvals, financial and operational outlook, growth strategies, collaborations and operating results - such as expected adjusted net sales and adjusted diluted earnings - are based on current expectations and assumptions. However, they involve uncertainties and risks. These risks include, but are not limited to, challenges in managing growth and international operations (including the effects of currency fluctuations, regulatory processes and logistical dependencies), variability in operating results, commercial development for our products to customers in the Life Sciences and clinical healthcare, changes in relationships with customers, suppliers or strategic partners; competition and rapid technological advancements; fluctuating demand for QIAGEN's products due to factors such as economic conditions, customer budgets and funding cycles; obtaining and maintaining regulatory approvals for our products; difficulties in successfully adapting QIAGEN's products into integrated solutions and producing these products; and protecting product differentiation from competitors. Additional uncertainties may arise from market acceptance of new products, integration of acquisitions, governmental actions, global or regional economic developments, natural disasters, political or public health crises, and other "force majeure" events. There is also no guarantee that anticipated benefits from restructuring programs and acquisitions will materialize as expected. For a comprehensive overview of risks, please refer to the 'Risk Factors' contained in our most recent Annual Report on Form 20-F and other reports filed with or furnished to the U.S. Securities and Exchange Commission.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
19 minutes ago
- Yahoo
ExchangeRight Welcomes Tracy Mousner as Senior Vice President of the Four Corners Region
PASADENA, Calif., July 24, 2025--(BUSINESS WIRE)--ExchangeRight, one of the nation's leading providers of diversified real estate REIT and DST investments, has announced the appointment of Tracy Mousner as senior vice president of the Four Corners region. In this role, Mousner will serve financial advisors and representatives across Colorado, Arizona, New Mexico, and Utah. He will focus on deepening relationships and equipping advisors with access to ExchangeRight's REIT and 1031 DST portfolios, which are structured to provide capital preservation, stable income, and tax-advantaged investment solutions. Mousner brings over 25 years of experience in financial services, having supported independent advisors, RIAs, and broker-dealers with alternative investment strategies and retirement income solutions. He holds Series 7, 22, 62, and 63 licenses and brings a deep understanding of advisor needs and long-term investment planning. "We are excited to welcome Tracy as we expand our presence in the Four Corners region," said Joshua Ungerecht, a managing partner at ExchangeRight. "His commitment to educating advisors and his track record of delivering client-focused investment strategies align strongly with our investor-centered approach." "ExchangeRight's disciplined investment strategy and strong values are what drew me to the team," said Mousner. "I look forward to supporting advisors with the resources and insights they need to help their clients benefit from our diversified offerings and proven track record of consistent performance." About ExchangeRight ExchangeRight and its affiliates' vertically integrated platform features more than $6.6 billion in assets under management that are diversified across over 1,300 properties, and 26 million square feet throughout 47 states, as of June 30, 2025. ExchangeRight pursues its passion to empower people to be secure, free, and generous through its Essential Income REIT and 1031 DST portfolios that target secure capital, stable income, and strategic exits, all of which have historically met or exceeded investor projections since ExchangeRight's inception. On behalf of our investors nationwide, the company structures and manages net-leased portfolios of assets backed primarily by investment-grade corporations that have successfully operated in the necessity-based retail and healthcare industries. Past performance does not guarantee future results. Please visit for more information. View source version on Contacts Media Contact Lindsey ThompsonSenior Media Relations Officerlthompson@ Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Business Wire
20 minutes ago
- Business Wire
Labaton Keller Sucharow LLP Files Securities Class Action Against Fiserv, Inc. and Certain of Its Executives
NEW YORK--(BUSINESS WIRE)--Labaton Keller Sucharow LLP ('Labaton') has filed a securities class action lawsuit (the 'Action') on behalf of its client the City of Hollywood Police Officers' Retirement System ('Hollywood Police') against Fiserv, Inc. ('Fiserv' or the 'Company') (NYSE: FI) and certain of its executives (collectively, 'Defendants'). The Action, which is captioned City of Hollywood Police Officers' Retirement System v. Fiserv, Inc., No. 25-cv- 06094 (S.D.N.Y.), asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and U.S. Securities and Exchange Commission Rule 10b-5 promulgated thereunder on behalf of all persons and entities that purchased or otherwise acquired Fiserv common stock between July 24, 2024 and July 22, 2025, inclusive (the 'Class Period'). Fiserv is a global provider of transaction processing software for banks and retail merchants. Fiserv's flagship product and most important growth driver is Clover, which provides merchants with a payment 'gateway' to facilitate the secure processing of credit, debit, and mobile payment transactions on behalf of financial institutions and their customers. The Action alleges that, throughout the Class Period, Defendants misled investors by failing to disclose that: (a) due to cost issues and other problems with its older Payeezy platform, Fiserv forced Payeezy merchants to migrate to its Clover platform; (b) Clover's revenue growth and gross payment volume ('GPV'), the total monetary value of transactions processed through Clover, were temporarily and unsustainably boosted by these forced conversions, which concealed a slowdown in new merchant business; (c) shortly after these conversions, a significant portion of former Payeezy merchants switched to competing solutions due to Clover's high pricing, significant down time, and systematic compatibility issues; (d) as a result of these merchant losses, Clover's GPV growth was significantly slowing, and its revenue growth was unsustainable; and (e) based on the foregoing, Fiserv's positive Class Period statements about Clover's growth strategies, competition, attrition, GPV growth, and business prospects were materially false and misleading. The market began to learn the truth about Defendants' fraud on April 24, 2025. On that date, Fiserv shocked investors by reporting Clover GPV growth of only 8 percent for the first quarter of 2025, a material stepdown from 2024 GPV rates of between 14 and 17 percent. The Company attributed this slowing growth to lower 2025 transaction volumes from Payeezy merchants who had converted to Clover. On this news, Fiserv stock dropped 18.5 percent, closing at $176.90 per share on April 24, 2025. Then, on May 15, 2025, Fiserv disappointed investors by disclosing that GPV growth deceleration would continue throughout 2025. On this news, Fiserv stock dropped 16.2 percent, closing at $159.13 per share on May 15, 2025. Finally, on July 23, 2025, Fiserv lowered the top end of its full-year organic growth guidance range and confirmed that its quarterly organic revenue in the Merchant segment had decelerated to 9 percent year-over-year from 11 percent in the previous quarter. On this news, Fiserv stock dropped 13.9 percent, closing at $143.00 per share on July 23, 2025. If you purchased or acquired Fiserv common stock during the Class Period and were damaged thereby, you are a member of the 'Class' and may be able to seek appointment as Lead Plaintiff. Lead Plaintiff motion papers must be filed no later than September 22, 2025. The Lead Plaintiff is a court-appointed representative for absent members of the Class. You do not need to seek appointment as Lead Plaintiff to share in any Class recovery in this action. If you are a Class member and there is a recovery for the Class, you can share in that recovery as an absent Class member. You may retain counsel of your choice to represent you in this action. If you would like to consider serving as Lead Plaintiff or have any questions about this lawsuit, you may contact Connor C. Boehme, Esq. of Labaton at (212) 907-0780, or via email at cboehme@ You can view a copy of the Complaint online here. Hollywood Police is represented by Labaton, which represents many of the largest pension funds in the United States and internationally with combined assets under management of more than $4.5 trillion. Labaton's litigation reputation is built on its half-century of securities litigation experience, more than ninety full-time attorneys, and in-house team of investigators, financial analysts, and forensic accountants. Labaton has been recognized for its excellence by the courts and peers, and it is consistently ranked in leading industry publications. Offices are located in New York, Delaware, London, and Washington, D.C. More information about Labaton is available at
Business Wire
20 minutes ago
- Business Wire
Triple-I/Whisker Labs: Study Shows Ting IoT Fire Safety Solution Reduces Annual Fire Damage Claims by $81 Per Home
MALVERN, Pa.--(BUSINESS WIRE)--A new study conducted by the Insurance Information Institute (Triple-I) and Whisker Labs, with support provided by Octagram Analytics, has found IoT-based fire prevention technology reduced a broad category of non-catastrophic fire claims by an estimated 63% within three years after installation. 'As property/casualty insurers increasingly focus on predicting and preventing costly damage that drives up claims and premiums, this study provides concrete evidence of the value that telematics technology can deliver." The analysis, which represents the first comprehensive quantitative analysis of home IoT claims reduction efficacy, found that Ting – a home fire prevention solution created by Whisker Labs – resulted in 0.39 fewer fire claims per 1,000 home years of experience. This translates into a fire claim reduction benefit of $81 per customer per year by the third year. 'As property/casualty insurers increasingly focus on predicting and preventing costly damage that drives up claims and premiums, this study provides concrete evidence of the value that telematics technology can deliver,' said Patrick Schmid, chief insurance officer at Triple-I. 'While IoT solutions are gaining traction with many success stories, rigorous analysis of claims reduction has been harder to find until now. This analysis clearly shows Ting reduces claims and provides a positive return on investment for insurers.' How the Technology Works Ting helps protect homes from electrical fires by using advanced AI to detect arcing, the precursor to most electrical fires. Once connected to a single outlet, Ting analyzes 30 million measurements per second, analyzing voltage at high frequencies to detect tiny electrical anomalies and power quality problems. These hazards can originate from wiring in the home, connected devices and appliances, or even the power coming in from the utility. On average, Ting detects and mitigates fire hazards in one out of every 60 homes it protects. 'Ting is about saving lives and homes - that's always been our mission,' said Bob Marshall, CEO and cofounder of Whisker Labs. 'By analyzing verified claims data over time, this analysis shows that what's best for families also delivers a strong financial return for insurers. Prevention is better for everyone.' The device also includes temperature monitoring capabilities, issuing alerts when temperatures drop below 42 degrees to prevent frozen and burst pipes. Over the past three years, low temperature warnings have been issued to approximately one in 560 customers annually. Study Methodology To overcome challenges related to limited data and sampling bias, the research team developed a self-controlled study that assessed claims over time in homes with Ting installed. The methodology was designed to measure real-world performance with existing customers and experience data. 'We developed a methodology to prove that home IoT technology can prevent losses in the real world,' said Stan Heckman, chief scientist at Whisker Labs. 'The challenge was demonstrating that claims didn't occur – essentially counting fires that never happened.' Using data from Triple-I and Verisk, the study determined Ting provides an average loss-prevention benefit of $81 per home per year from fire claims reduction alone, demonstrating a compelling return on investment for insurers. Additional benefits from water-related loss prevention and potential improvements in customer retention suggest the total value may be substantially higher. Market Adoption More than 1 million Ting sensors are currently deployed across the United States, with approximately 50,000 new installations each month. A growing community of 30 property/casualty insurers now provide Ting to their customers at no charge. About the Insurance Information Institute (Triple-I) Since 1960, the Insurance Information Institute (Triple-I) has been the trusted voice of risk and insurance, delivering unique, data-driven insights to educate, elevate and connect consumers, industry professionals, policymakers and the media. An affiliate of The Institutes, Triple-I represents a diverse membership accounting for nearly 50% of all U.S. property/casualty premiums written. Our members include mutual and stock companies, personal and commercial lines, primary insurers and reinsurers – serving regional, national and global markets. About The Institutes The Institutes® are a global not-for-profit comprising diverse affiliates that educate, elevate and connect people in the essential disciplines of risk management and insurance. Through products and services offered by The Institutes' nearly 20 affiliated business units, people and organizations are empowered to help those in need with a focus on understanding, predicting and preventing losses to create a more resilient world. The Institutes is a registered trademark of The Institutes. All rights reserved. About Whisker Labs Whisker Labs develops cutting-edge sensor technology to protect families, homes, and communities by predicting and preventing electrical fires while also monitoring the resiliency and safety of the U.S. electrical grid. Through a single, DIY sensor plugged into a wall outlet, Ting, Whisker Labs' flagship solution, enables intelligent detection, localization, and mitigation of hazards before they can start a fire. As one of the fastest growing grid IoT networks, Ting is proven to prevent 4 out of 5 home electrical fires, reducing home fire losses and saving lives across the U.S. every day. Follow us on LinkedIn, X, Instagram and Facebook. About Octagram Analytics Octagram Analytics is a data and analytics consulting firm specializing in property and casualty insurance. The company focuses on helping clients leverage data to improve pricing, underwriting, and overall business performance. Octagram offers both consulting services and tools designed to help clients develop and implement data-driven strategies.
